UATG News Alert Umbra Applied Technologies Group Inc. (UATG)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Umbra Applied Technologies Group Inc. (UATG) 0.7500 $UATG

Umbra Applied Technologies Group Begins Natural Gas Production
Marketwire - Tue Aug 19, 9:30AM CDT
Intrepid Energy, a subsidiary of Umbra Applied Technologies Group (OTC: UATG) has achieved another milestone developing a diversified revenue stream within its Mississippi Lime Portfolio. Its CEO Justin Herman announced today that it has successfully begun its plans to receive revenue from its natural gas assets within the portfolio when he said, "Today we begin the next phase of our Clean Energy Initiative with the implementation of our natural gas production operations."

Umbra Applied Technologies Group Launches UBR-16 Military Rifle
Marketwire - Thu Aug 14, 7:45AM CDT
Umbra Applied Technologies (UAT), an Umbra Applied Technologies Group, Inc. company (OTC: UATG), announced today that it has completed the final design of its highly anticipated Umbra Battle Rifle the UBR-16. After exhaustive research and testing, the much talked about UBR-16 is ready for delivery to government agencies for preliminary field testing.

Umbra Applied Technologies Group Debuts New Property With Oil Sales
Marketwire - Tue Aug 12, 9:10AM CDT
Intrepid Energy, a subsidiary of Umbra Applied Technologies Group (OTC: UATG) has begun to sell oil from a second property within its Mississippi Lime formation portfolio. The refinery scheduled the first delivery of crude for this afternoon. Justin Herman, CEO, of Intrepid Energy, commented that "Production from a second property is a major achievement for us. It's our goal to produce oil from four of our properties before the end of 2014."

Umbra Applied Technologies Group's, Intrepid Energy, Commences Oil Sales
Marketwire - Mon Aug 04, 8:15AM CDT
Intrepid Energy, a subsidiary of Umbra Applied Technologies Group (OTC: UATG) announced today that it has begun to sell oil. The oil sale comes from the company's Bales lease consisting of 80 acres within the company's Mississippi Lime portfolio in southeastern Kansas. Justin Herman, CEO, of Intrepid Energy, commented, "This is quite an accomplishment for such a young company. It's a modest beginning as we work towards achieving our ultimate goal of creating an energy farm." The company anticipates further oil sales and is working towards diversifying its production with natural gas sales.

Umbra Applied Technologies Group's, Intrepid Energy, Completes Two Refinery Agreements
Marketwire - Fri Aug 01, 8:50AM CDT
Intrepid Energy, a subsidiary of Umbra Applied Technologies Group (OTC: UATG), has completed a sales agreement with two refineries. Justin Herman, CEO, of Intrepid Energy, commented, "Our goal was to create the most cost efficient pathway to deliver our product to market. We now have refinery options and enhanced choices with crude haulers within our operational footprint. These agreements will allow us to maximize the value of our oil & gas portfolio." Initial sales will come from the company's portfolio within the Mississippi Lime formation. Intrepid Energy will be one of the first companies to supply crude oil produced in part with clean technology provided by its sister companies ChaseDown and Umbra Applied Technologies GreenTech division.

UATG Subsidiary, Intrepid Energy, Acquires New Acreage
Marketwire - Wed Jul 30, 8:15AM CDT
Umbra Applied Technologies Group, Inc. (OTC: UATG) -- Intrepid Energy Corporation has procured a vital location within the oil and gas rich area of Southeastern Kansas. The newly acquired asset is nestled in what often times are referred to as the Kansas Ozarks, gateway to the Flint hills of Kansas. The Jones lease is 160 acres with strong geological records that reflects great promise oil and gas production. Intrepid Energy CEO Justin Herman commented, "This acquisition is helping build our acreage portfolio and we are excited about the geological promise that this purchase contributes to plans."

Umbra Applied Technologies Group Begins Oil Production
Marketwire - Fri Jul 25, 8:30AM CDT
Intrepid Energy Corporation, an Umbra Applied Technologies Group company (OTC: UATG), announced today that it has started oil production. CEO of Umbra Applied Technologies Group, Alex Umbra commented that, "Today is yet another milestone in the development of our company, as we begin to transform the potential of a promising company into realized shareholder value. I congratulate our team on yet another successful step towards our plan to build a diversified energy farm."

Umbra Applied Technologies Group Debuts ChaseDown With Sales
Marketwire - Mon Jul 21, 8:15AM CDT
Intrepid Energy Corporation, an Umbra Applied Technologies Group company (OTC: UATG), debuted its latest product, ChaseDown(TM), a proprietary enhanced oil recovery (EOR) technology. ChaseDown is an emulsion base substrate developed to assist in the recovery and extraction of heavy based hydrocarbons that enhances separation of hydrocarbons saturated with high metals and paraffin content. Extensive field and lab tests have proven ChaseDown to be superior to other products by permanently reducing the viscosity of heavy oil at ambient temperatures. ChaseDown does not require external heat and works very well at typical storage temperatures.

Umbra Applied Technologies Introducing the Apex(TM) Digital Joint Implant
Marketwire - Tue Jul 15, 10:12AM CDT
Umbra Applied Technologies (OTC: UATG) has created a product through next generation innovation and initiated a paradigm shift within an industry. The Apex(TM) Digital Joint Implant is a revolutionary new interphalangeal implant that has put an entire industry on notice. CEO Alex Umbra commented that, "The launch of Apex Digital Joint Implant is yet another milestone in our company's history." The Apex implant is the world's first and only fully ceramic permanent implant that bone will grow to which never needs to be replaced. Apex(TM) is made of a special biocompatible ceramic material that is stronger than steel, making it the world's first fully ceramic joint implant with which bone will actually grow and adhere to. The stems of the Apex(TM) implant are bioactive and interact with osteoblasts to promote bone growth and adhesion.

Umbra Applied Technologies Group's Intrepid Energy Announces Licensure as Oil and Gas Producer in State of Kansas; Targets Mississippi Lime Formation
Marketwire - Fri Jul 11, 2:45PM CDT
Intrepid Energy, an Umbra Applied Technologies Group company (OTC: UATG), is now a licensed oil and gas producer in the state of Kansas. The company is targeting the Mississippi Lime Formation in its first step in a comprehensive energy initiative. Chairman and CEO Alex Umbra, offered, "Today's announcement is just the first step in our long term plan to integrate green energy with traditional energy sources. We have begun the process to create an 'energy farm' that will integrate our clean energy platforms with conventional oil and gas reclamation operations. UATG is proud to contribute in no small way to American energy independence."

Umbra Applied Technologies Group Continues Expansion With Launch of New Website
Marketwire - Thu Jun 12, 8:02AM CDT
Umbra Applied Technologies Group, corporate offices (OTC: UATG) announced today that it has launch its new website www.uatgroup.com.

Umbra Applied Technologies Group Introduces New Blood Management System Powered by Cellgevity(TM)
Marketwire - Thu Mar 13, 8:18AM CDT
Umbra Applied Technologies Group (OTC: UATG) announces today that its Biotech Division has finalized agreements that will enable the Company(UTA) to bring forward the greatly anticipated blood preservation treatment Propestat(TM). Propestat(TM) is the backbone of UAT's Cellgevity(TM) brand found only in the much-anticipated Blood Management System.

Umbra Applied Technologies Group Introduces Propestat
Marketwire - Fri Mar 07, 8:41AM CST
Intrepid Innovations Corporation, an (OTC:UATG )company, announced that its wholly owned subsidiary, Intrepid Medical Technologies Corporation, has introduced its blood product storage and preservation product, Propestat. The CEO of Intrepid Innovations Corporation, Chuck Winters, commented that, "Propestat, has the potential to be a paradigm shifting technology in blood product storage and platelet preservation."

ProtoKinetix Completes Sale of Exclusive Rights for AAGP(TM) Blood Preservation Applications
Business Wire - Wed Mar 05, 9:48AM CST
ProtoKinetix (OTC KTX) (www.protokinetix.com) has announced the sale of one of the numerous cell protection applications that prove to significantly increase the shelf life of delicate cells and organs by the addition of AAGP(TM). The purchaser, Intrepid Innovations Corporation, is a wholly owned subsidiary of Umbra Applied Technologies Group (OTC:UATG) and has been funded to address the world-wide demand for blood product storage, and platelet preservation.

Umbra Applied Technologies Group Announces Launch of Intrepid Energy Corporation
Marketwire - Tue Mar 04, 7:31AM CST
Intrepid Innovations Corporation (OTC: UATG) announced that it has formed Intrepid Energy Corporation, a company created to develop and complement our existing energy and natural resource business. Chuck Winters, Chief Executive Officer, of Intrepid Innovations, commented that, "Over the last year, we have made significant strides in developing alternative energy technologies, building our energy infrastructure, establishing relationships with new customers and expanding our relationships with existing customers," Mr. Winters further explained, "We believe this will enable Intrepid Energy to introduce new technologies to an existing market segment while capturing a substantial share of emerging markets. The introduction of this new subsidiary represents a firm commitment to our core business model and mission statement while extending our existing market position in the more established natural gas and oil markets."

Umbra Applied Technologies Group, Inc. Announces UAT ARMS Division and UBR-16
Marketwire - Tue Feb 18, 8:10AM CST
Umbra Applied Technologies Group, Inc. (OTC: UATG), a diversified holdings company, is pleased to announce the launch of UAT ARMS, a new division of the company created to design, manufacture, and support the next generation of American born weapons. Chairman and CEO Alexander L. Umbra was quoted as saying "UAT ARMS is inspired by an unyielding sense of patriotism and a profound sense of responsibility to create the most highly efficient and reliable weapons platforms. Our inspiration can be seen in the genesis of our first product, the Umbra Battle Rifle (UBR-16)."




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Voter Events by Valley Community Healthcare Aim to Empower

Updated Category News Views 39

Here's a game-changer for the community. Valley Community Healthcare (VCH) is stepping up, proving that healthcare doesn't just stick to check-ups and prescriptions. It's about the whole shebang—community empowerment included. This October, VCH is hosting two incredible voter events, collaborating with the Los Angeles County Registrar-Recorder's Mobile Voting Program....

Continue Reading
Weifang's Cultural Resurgence: A Global Epigraphy Fest

Updated Category News Views 46

A Historical Meltdown into Global Recognition Welcome to the ride where ancient stones talk and cultural borders vanish. We're diving into the beating heart of Weifang, a place you're probably hearing about now because the town's hosting a packed international media tour. And, for a change, this isn't just another tourist trap; it's a cultural adrenaline shot to the arm,...

Continue Reading
AEVEX Facing Class Action Deadline Amid Stock Turmoil

Updated Category News Views 48

Investors are no strangers to the rough and tumble of stock markets, but things get downright messy when trust is shattered. That's the sorry saga unfolding with AEVEX, where shareholders are feeling the heat after a sharp nosedive in stock value. The clock is ticking to join the class action, and any AEVEX investor worth their salt should pay attention. Unraveling...

Continue Reading
Masimo's smartSET™ Revolutionizes Patient Monitoring

Updated Category News Views 44

Breaking Ground in Patient Monitoring Let's dive into the gritty details behind Masimo's latest FDA-nod: the smartSET™ system. This gizmo ain't your ordinary pulse oximeter; it's a next-gen hand-holder for the medical world, poised to ride the AI wave straight into the clinic. They've cracked open a new way for clinicians to peek behind the curtain of patient vitals,...

Continue Reading
LG OLED evo W6: UAE Roadshow Starts with a Bang

Updated Category News Views 50

They've done it again, folks. LG Electronics is out there kicking up a storm with their all-new OLED evo W6 True Wireless Wallpaper TV, and they're bringing the action straight to the UAE's doorsteps. Imagine taking a stroll and stumbling upon this technological marvel at some fancy spot like The Lotus Lounge at Anantara The Palm Dubai Resort. This ain't just a TV, it's a...

Continue Reading
Innventure Faces Major Lawsuit Over Misleading Investors

Updated Category News Views 61

Missteps at Innventure: A Costly Lesson in Investor Trust The stock market is no stranger to drama, but Innventure's saga feels like a page ripped right out of a thriller novel. You’ve got accusations, alleged fabrications, and a swift drop in stock prices that’s left some investors shaking their heads. The company, nestled under the ticker NASDAQ:INV, finds itself...

Continue Reading
Hyliion Class Action Deadline Nears for Investors

Updated Category News Views 58

Potential Shockwaves for Hyliion Investors Investors are having a showdown with Hyliion (NYSE:HYLN) these days. With the looming October 27, 2026, deadline to jump into a securities class action, it seems Hyliion's latest escapade smells worse than a fish market on a hot day. We’ve got allegations here stronger than your uncle’s morning coffee. Understanding the Legal...

Continue Reading

Top 5 Most Recently Viewed Articles

Cemtrex's Stock Surge Sparks Interest in Leading Movers

Updated Category News Views 117

Cemtrex Experiences Notable Share Surge Shares of Cemtrex, Inc. CETX have seen a significant uptick amid pre-market trading. This boost comes on the heels of better-than-expected sales in the latest quarter, reporting an impressive $18.10 million in sales, surpassing the general analyst expectation of $16.39 million. This remarkable performance in sales has sparked...

Continue Reading
Exciting New PharmD-MBA Pathway Combines Pharmacy and Business

Updated Category News Views 193

Collaboration between Cal Poly Pomona and Western University In an exciting move, Cal Poly Pomona's Singelyn Graduate School of Business and Western University of Health Sciences have teamed up to create a groundbreaking pathway for aspiring healthcare professionals. This innovative PharmD-MBA program combines the fields of pharmacy and business, providing a unique...

Continue Reading
Kaskela Law Investigates Stock Misconduct in Stanley Black & Decker

Updated Category News Views 155

Overview of the Investigation by Kaskela Law LLC Kaskela Law LLC has announced an important investigation focused on Stanley Black & Decker, Inc. (NYSE: SWK) concerning allegations of potential securities fraud. This inquiry is primarily aimed at safeguarding the interests of long-term investors who hold shares in this well-known manufacturing company. Details Surrounding...

Continue Reading
Legend Biotech's Carvykti: A Leading Force in Cancer Treatment

Updated Category News Views 90

Redburn's Positive Outlook for Legend Biotech Recently, Redburn-Atlantic began covering Legend Biotech Corp. (NASDAQ: LEGN) with a favorable Buy rating and set a price target of $86.00 for the stock. This biotechnology company has made significant strides, particularly with the recent approval of its innovative product, Carvykti, designed for the treatment of multiple...

Continue Reading
Transforming the Anti-Obesity Drug Market for Future Success

Updated Category News Views 132

Global Anti-Obesity Drug Market Overview As global health concerns rise, the demand for anti-obesity drugs is surging. Recent reports estimate that the anti-obesity drug market will soar to USD 82.55 billion in the coming years. This impressive growth, fueled by an anticipated compound annual growth rate (CAGR) of 18.01%, signals a crucial moment for pharmaceutical...

Continue Reading